The use of selective serotonin reuptake inhibitors among Swedish psychiatrists. Results of a questionnaire

Nordic Journal of Psychiatry

Volumn 50, Issue 6, 1996, Pages 443-450

  Mårtensson, Björn ^a   Åberg Wistedt, Anna ^b  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b ST GÖRAN S HOSPITAL   (Sweden)

Author keywords

Depression; Questionnaire; Selective serotonin reuptake inhibitor

Indexed keywords

ANTIDEPRESSANT AGENT; BUSPIRONE; MIANSERIN; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

AGITATION; ARTICLE; CONFUSION; DEPRESSION; DISEASE SEVERITY; DRUG USE; HUMAN; IRRITABILITY; MENTAL DISEASE; MYOCLONUS; PSYCHIATRIST; QUESTIONNAIRE; RESTLESSNESS; SEXUAL DYSFUNCTION; SWEDEN; TREMOR; WITHDRAWAL SYNDROME;

EID: 0029905879     PISSN: 08039496     EISSN: None     Source Type: Journal    
DOI: 10.3109/08039489609082512     Document Type: Article

References (27)

1. Mårtensson B, Åberg-Wistedt A. Selektiva hämmare av serotoninupptag. Ny grupp av antidepressiva medel ökar i användning. Lakartidningen 1994;91:3371-9.
2. Boyer W. Serotonin uptake inhibitors are superior to imipramine and alprazolam in alleviating panic attacks: a meta-analysis. Int Clin Psychopharmacol 1995;10:45-9.
3. Oehrberg S, Christiansen PE, Behnke K, Borup AL, Soegaard J, Calberg H, et al. Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebocontrolled study. Br J Psychiatry 1995;167:374-9.
4. Stein DJ, Spadaccini E, Hollander E. Meta-analysis of pharmacotherapy trials for obsessive-compulsive disorder. Int Clin Psychopharmacol 1995;10: 11-8.
5. Greist JH, Jefferson JW, Kobak KA, Chouinard G, Duboff E, Halaris A, et al. A 1 year double-blind placebo-controlled fixed dose study of sertraline in the treatment of obsessive-compulsive disorder. Int Clin Psychopharmacol 1995;10:57-65.
6. Danish University Antidepressant Group. Citalopram: clinical effect profile in comparison with clomipramine. A controlled multicenter study. Psychopharmacology 1986;90:131-8.
7. Danish University Antidepressant Group. Paroxetine: a selective reuptake inhibitor showing better tolerance, but weaker antidepressant effect than clomipramine in a controlled multicenter study. J Affect Disord 1990;18:289-99.
8. Roose SP, Glassman AH, Attia E, Woodring S. Comparative efficacy of selective serotonin reuptake inhibitors and tricyclics in the treatment of melancholia. Am J Psychiatry 1994;151:1735-9.
9. Tignol J. Treatment of severe depression with paroxetine. Eur Psychiatry 1993;8 Suppl 1:21s-3s.
10. Nierenberg AA. The treatment of severe depression: is there an efficacy gap between SSRI and TCA antidepressant generations? J Clin Psychiatry 1994;55 Suppl A:55-9.
11. Montgomery SA, Pedersen V, Tanghøj P, Rasmussen C, Rioux P. The optimal dosing regimen for citalopram-a meta-analysis of nine placebo-controlled studies. Int Clin Psychopharmacol 1994;9 Suppl 1:35-40.
12. Clerc GE, Ruimy P, Verdeau-Paillès J, on behalf of the Venlafaxine French Inpatient Study Group. A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholia. Int Clin Psychopharmacol 1994;9:139-43.
13. Katona CLE, Abouh-Saleh MT, Harrison DA, Nairac BA, Edwards DRL, Lock T, et al. Placebo-controlled trial of lithium augmentation of fluoxetine and lofepramine. Br J Psychiatry 1995;166:80-6.
14. Medhus A, Heskestad S, Tjemsland L. Mianserin added to tricyclic antidepressants in depressed patients not responding to a tricyclic antidepressant alone. Nord J Psychiatry 1994;48:355-8.
15. Joffe RT, Schuller DR. An open study of buspirone augmentation of serotonin reuptake inhibitors in refractory depression. J Clin Psychiatry 1993;54: 269-71.
16. Artigas F, Perez V, Alvarez E. Pindolol induces a rapid improvement of depressed patients treated with serotonin reuptake inhibitors. Arch Gen Psychiatry 1994;51:248-51.
17. Fava GA, Grandi S. Withdrawal syndromes after paroxetine and sertraline discontinuation. J Clin Psychopharmacol 1995;15:374-5.
18. Sternbach H. The serotonin syndrome. Am J Psychiatry 1991;157:705-13.
19. Beaumont G. Sexual side-effects of clomipramine (Anafranil). J Int Med Res 1973;1:469-72.
20. Salzman. Dealing with the sexual side effects of SSRI antidepressants. J Prac Psych Behav Health 1995:37-9.
21. Stein DJ, Hollander E. Sexual dysfunction associated with the drug treatment of psychiatric disorders. Incidence and treatment. CNS Drugs 1994; 2:78-86.
22. Wålinder J. Comparative efficacy and safety of selective serotonin reuptake inhibitors in the short-and medium-term treatment of major depressive disorders. Nord J Psychiatry 1996;50:55-9.
23. Aguglia E, Casacchia M, Cassano GB, Faravelli C, Ferrari G, Giordano P, et al. Double blind study of the efficacy and safety of sertraline versus fluoxetine in major depression. Int Clin Psychopharmacol 1993;8:197-202.
24. Ansseau M, Gabriels A, Loyens J, Bartholome F, Evrard JL, De Nayer A, et al. Controlled comparison of paroxetine and fluvoxamine in major depression. Human Psychopharmacol 1994;9:329-36.
25. Brown WA, Harrison W. Are patients who are intolerant to one serotonin selective reuptake intolerant to another? J Clin Psychiatry 1995;56:30-4.
26. Nemeroff CB, De Vane CL, Pollock BG. Newer antidepressants and the cytochrome P450 system. Am J Psychiatry 1996;153:311-20.
27. Kramer PD. Listening to Prozac. New York: Penguin Books, 1994.